基本信息
姓名: 陈天辉 性别: 男
学历: 研究生 学位: 博士(硕导)
职称: 研究员 出生年份: 1975-02
博导类型: 博导专业: —— 博导学院: ——
硕导类型: 学术型 硕导专业: 肿瘤学 硕导学院: 第二临床医学院
Email: chenth@zjcc.org.cn 联系电话: 0571-88122588
研究方向: ①恶性间皮瘤和BAP1癌症综合征；②肿瘤登记随访及监测大数据挖掘(5年相对生存率的精准评估及预测)；③肿瘤早期发现、诊断及预防；④家族性及多原发肿瘤的遗传流行病学(侧重结直肠癌、乳腺癌/卵巢癌/胰腺癌等)
工作单位: 浙江省肿瘤医院
发表论文

1、Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017,Zhai Z#,Chen Tianhui*, Dai Zhijun*,JAMA Network Open,SCI,2021-08,Zhejiang University,中科院医学一区TOP,8.483,4(8):e2120360

2、Using population-based cancer registration data and period analysis to accurately assess and predict 5-year relative survival for lung cancer patients in eastern China,Zhai Z#,Chen Tianhui*, Dai Zhijun*,Frontiers in Oncology,SCI,2021-05,Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Q2,6.244,11:661012
3、Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden,Kari Hemminki,Kari Hemminki*, Tianhui Chen*,BMC Cancer,SCI,2021-11,Charles University in Prague,Q3,4.43,21(1):1189
4、Multi-infection patterns and co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across China,Liao G,Tianhui Chen,Frontiers in Oncology,SCI,2020-01,Sichuan University,Q2,4.137,10:449
5、Assessment of longterm survival of cancer patients using cancer registry data from eastern China: period analysis is superior to traditional methods,1. Jiang X,Tianhui Chen,International Journal of Cancer,SCI,2020-01,Zhejiang Academy of Medical Sciences,Q1,4.982,PMID: 31943167
6、High time for complete ban on asbestos use in developing countries,Tianhui Chen,Tianhui Chen,JAMA Oncology,SCI,2019-05,Zhejiang Academy of Medical Sciences,Q1,22.416,779-780
7、Multiple primary (even in situ) melanomas in a patient pose significant risk to family members,Tianhui Chen,Tianhui Chen,European Journal of Cancer,SCI,2014-10,German Cancer Research Center,Q1,5.417,2659-67.
8、Epidemiology of gynecologic cancer in China,Xiyi Jiang,Tianhui Chen,Journal of Gynecologic Oncology,SCI,2018-01,Zhejiang Academy of Medical Sciences,Q3,2.914,1-7
9、Response: Methods for second primary cancers evaluation have to be standardized,Tianhui Chen,Tianhui Chen,International Journal of Cancer,SCI,2018-03,Zhejiang Academy of Medical Sciences,Q1,4.982,1286-7
10、Type 1 Diabetes in parents and risk of attention deficit hyperactivity disorder in offspring: a population-based study in Sweden,Jianguang Ji & Tianhui Chen(共同第一),Jianguang Ji,Diabetes Care,SCI,2018-04,Lund University, Sweden,Q1,15.270,770-774
11、Prognosis prediction of colorectal cancer using gene expression profiles,Feixia Pan & Tianhui Chen(共同第一),Yimin Zhu,Frontiers in Oncology,SCI,2019-04,Zhejiang University,Q2,4.417,1-7
12、Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study,Elham Kharazmi,Elham Kharazmi&Tianhui Chen(共同通讯作者),European Journal of Cancer,SCI,2018-11,German Cancer Research Center,Q1,6.680,1-6
13、Diagnostic value of methylated Septin9 for colorectal cancer detection,Li Xie,Dong Li &Tianhui Chen（共同通讯作者）,Frontiers in Oncology,SCI,2018-07,Shanghai First People's Hospital,Q2,4.416,1-8
14、Hand-spinning chrysotile exposure and risk of malignant mesothelioma: A case-control study in Southeastern China,Zhaoqiang Jiang& Tianhui Chen(共同第一),Xin Zhang,International Journal of Cancer,SCI,2018-02,Zhejiang Academy of Medical Sciences,Q1,4.982,514-523
15、Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries,Tianhui Chen,Tianhui Chen,International Journal of Cancer,SCI,2017-12,Zhejiang Academy of Medical Sciences,Q1,7.360,2270-2280
16、Risk of second primary cancers after malignant mesothelioma and vice versa,Tianhui Chen,Tianhui Chen,Cancer Letters,SCI,2016-05,Zhejiang Academy of Medical Sciences,Q1,6.375,94-99
17、Risk of second primary cancers in multiple myeloma survivors in German and Swedish cancer registries,Tianhui Chen,Tianhui Chen,Scientific Reports,SCI,2016-02,German Cancer Research Center,Q2,4.259,1-8
18、Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries,Tianhui Chen,Tianhui Chen,Cancer Letters,SCI,2015-12,German Cancer Research Center,Q1,5.992,152-166
19、Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas,Tianhui Chen,Tianhui Chen,JAMA Dermatology,SCI,1899-12-31 00:00,German Cancer Research Center,Q1,5.097,607-615
科研项目

1、常见恶性肿瘤联合筛查智能技术的研发及应用评价,陈天辉,浙江省肿瘤医院,国家科技部,“十四五”国家重点研发计划“常见多发病防治研究”重点专项课题,2021-12,2024-11,550,0

2、中国人群BRCA突变标准数据库的构建, 解析及其临床应用研究,陈天辉,浙江省肿瘤医院,国家科技部,国家重点研发计划“政府间/港澳台”重点专项项目,2020-12,2023-11,139,0
3、常见高发恶性肿瘤诊治新技术应用研究---新一代乳腺癌高危人群体外分子筛查技术研究：基于血液的遗传性易感基因组合(gene panel)及其试剂盒研发,陈天辉,浙江省医学科学院,浙江省科技厅,省重点研发计划,2017-01,2021-03,250,0
4、癌症病人长期生存的精准评估：基于周期分析（period analysis）技术和基于人群的癌症登记数据库,陈天辉,浙江省医学科学院,国家卫生部-浙江省卫生厅,省部共建重点项目,2017-01,2020-12-31 23:55,15,15
5、结直肠癌专病队列研究,陈天辉,浙江省医学科学院,国家科技部,国家重点研发计划子课题（分课题）,2017-01,2020-12-31 23:55,10,0
6、基于前瞻性队列的中德癌症合作研究平台,陈天辉,浙江省医学科学院,国家外专局,国家外专局重点项目,2018-01,2019-12,20,0
科研成果

1、,,,,,,
个人信息

陈天辉教授，研究员，博士，现任浙江省肿瘤医院PI、防治科副主任，中科院医学所-澳门大学联合培养博士生导师，国家重点研发计划“政府间国际科技创新合作”重点专项项目首席专家，曾在欧洲工作十年(其中德国国家癌症研究中心DKFZ七年)。致力于临床流行病学、肿瘤分子流行病学研究，聚焦：①间皮瘤病因；②肿瘤登记随访及监测大数据挖掘(5年相对生存率的精准评估及预测)；③肿瘤早期发现、诊断及预防；④家族性及多原发肿瘤的遗传流行病学(侧重结直肠癌、乳腺癌/卵巢癌/胰腺癌等)。累计发表SCI论文74篇，其中36篇是通讯/第一作者论文(平均IF=5.8分/篇），包括3篇JAMA子刊(JAMA Oncology, JAMA Network Open, JAMA Dermatology)。2016年回国工作后主持十三五国家重点研发计划“政府间国际科技创新合作”重点专项项目、“十四五”国家重点研发计划“常见慢性病防治研究”重点专项课题、国家外专局重点项目、省重点研发计划项目、省部共建重点项目、省钱江人才项目等，主参(承担经费)国家自然科学基金委“中德科学中心合作交流项目(Mobility)”及十三五国家重点研发计划“精准医学研究“重点专项项目。兼任浙江省科学技术奖行业评审专家及省“尖兵”“领雁”研发攻关计划项目会评专家、Frontiers in Oncology(IF=6.2)“肿瘤流行病学与预防”栏目Associate Editor、Frontiers in Molecular Biosciences(IF=5.2)“分子诊断和治疗”栏目Guest Associate Editor。主编专著《肿瘤长期生存的精准评估与预测：周期法理论及实践》。